Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Zogenix Inc. : Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2013 | 02:40pm CEST
Conference Call Scheduled for May 9, 2013 at 4:30 pm ET

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial (866) 318-8616 (U.S.) or (617) 399-5135 (International); participant passcode: 65838569.

The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.

A replay of the conference call will be available beginning May 9, 2013 at 6:30 p.m. ET (3:30 p.m. PT) until May 16, 2013, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 23471504. A replay of the webcast will also be accessible on the Investor Relations website for one month, through June 9, 2013.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, Zohydro™ ER (hydrocodone bitartrate), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER. Zogenix's second investigational product candidate, Relday™, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia; an investigational new drug application was submitted to the FDA in May 2012. For additional information, please visit www.zogenix.com.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Caitlin Cox | The Ruth Group
         646.536.7033 | ccox@theruthgroup.com
Zogenix
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news
Date Title
06:36a MITSUBISHI AIRCRAFT : Personnel Change
06:36a EDEN ENERGY : Successful A$10.35 Million Capital Raising
06:36a EDEN ENERGY : Cleansing Notice
06:31a EDEN ENERGY : Change of Director's Interest Notice
06:31a EDEN ENERGY : Appendix 3B
06:31a UNITED ENERGY : POLL RESULTS AT ANNUAL GENERAL MEETING HELD ON 27 May 2016
06:30a KERR MINES : Arizona Mining announces $18 million underwritten private placement
06:26a GRAND FLO SOLUTION BHD : Others - Proposed Extension of Profit Guarantee Period to Include Financial Period Commencing 1 January 2016 abd Ending 31 December 2016
06:26a TAIWAN FAMILYMART : 2016/05/27 Taiwan FamilyMart consolidated revenue reached 4.77 billion in April 2...
06:25aDJNo Call From G-7 for Coordinated Spending
Latest news
Advertisement
Hot News 
MAY 31 DEADLINE ALERT : GPM Reminds Investors of the Looming Deadline in the Class Action Lawsuit Against DS Healthcare Group, Inc.
BARRETT BUSINESS SERVICES : stock jumps on 2015 profit report
DOLLAR TREE : now combined with Family Dollar, reports first quarter $233 million profit
JUVENTUS FOOTBALL CLUB : Champions League final in Milan highlights Serie A's crisis
DOLLAR GENERAL : Farmers market opening Friday in Slatington will be feeding a need
Most Read News
05/26 Asia stocks edge up after U.S. data, dollar consolidates month's gains
05/26 Oil prices retreat from $50 on oversupply concerns, stronger dollar
Most recommended articles
12:25aDJNo Call From G-7 for Coordinated Spending
05/26 U.S. panel launches trade secret theft probe into China steel
05/26DJOil Falls Below $50 on Profit-Taking; OPEC Meeting in Focus
05/26 Valeant rejected joint takeover bid from Takeda, TPG in spring - source
05/26 Oil prices retreat from $50 on oversupply concerns, stronger dollar